Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

EME2 and its functional interaction with MUS81 as a novel tumor suppressor

EF 2016-17

Résumé
When a cell divides, the entire genome must be duplicated accurately to ensure that both of the new daughter cells possess an identical genome to the parent cell. To accomplish this, DNA replication pathways and DNA damage repair pathways must interact synergistically and in a highly regulated fashion to ensure the accurate transmission of genomic material. When errors occur during this process, alterations to the genome of the daughter cells may occur. Genomic instability refers to an increased occurrence of genomic alterations during cellular divisions. Genomic instability is a hallmark of most cancers and is thought to be one of the driving factors for carcinogenesis in both humans and in mice. MUS81 is a structure selective endonuclease that functions as a heterodimer in complex with either EME1 or EME2. MUS81 deficiency has been shown to increase genomic instability and drive tumorigenesis in mouse models. Currently, there are not many studies on the role of EME2 as a tumor suppressor or guardian of genomic stability. Preliminary data from our lab suggests that while EME2 deficiency in C57BL/6 mice causes spontaneous development of lymphoma, C57BL/6 mice deficient in both MUS81 and EME2 do not develop tumors of any kind. I will be examining the mechanisms by which EME2 deficiency promotes tumorigenesis as well as the mechanism by which MUS81 and EME2 deficiency protects C57BL/6 mice from carcinogenesis. Characterizing EME2 and its relationship with MUS81 will provide insight into the relationship between genomic instability and tumorigenesis while simultaneously identifying new cancer biomarkers and therapeutic targets for cancer therapy.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367119
Name
Gautreau Brandon A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
EME2 and its functional interaction with MUS81 as a novel tumor suppressor
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Eme2; Genomic Instability; Ipond; Mus81; Replication Stress; Tummor Suppressors
Abstract
When a cell divides, the entire genome must be duplicated accurately to ensure that both of the new daughter cells possess an identical genome to the parent cell. To accomplish this, DNA replication pathways and DNA damage repair pathways must interact synergistically and in a highly regulated fashion to ensure the accurate transmission of genomic material. When errors occur during this process, alterations to the genome of the daughter cells may occur. Genomic instability refers to an increased occurrence of genomic alterations during cellular divisions. Genomic instability is a hallmark of most cancers and is thought to be one of the driving factors for carcinogenesis in both humans and in mice. MUS81 is a structure selective endonuclease that functions as a heterodimer in complex with either EME1 or EME2. MUS81 deficiency has been shown to increase genomic instability and drive tumorigenesis in mouse models. Currently, there are not many studies on the role of EME2 as a tumor suppressor or guardian of genomic stability. Preliminary data from our lab suggests that while EME2 deficiency in C57BL/6 mice causes spontaneous development of lymphoma, C57BL/6 mice deficient in both MUS81 and EME2 do not develop tumors of any kind. I will be examining the mechanisms by which EME2 deficiency promotes tumorigenesis as well as the mechanism by which MUS81 and EME2 deficiency protects C57BL/6 mice from carcinogenesis. Characterizing EME2 and its relationship with MUS81 will provide insight into the relationship between genomic instability and tumorigenesis while simultaneously identifying new cancer biomarkers and therapeutic targets for cancer therapy.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gautreau, Brandon A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~